JMJhonatan R. Mejia

Jhonatan R. Mejia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jhonatan R. Mejia has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Infecciones respiratorias virales agudas en niños antes y durante la pandemia de COVID-19 en un hospital de referencia peruano

    by Jhonatan R. Mejia, Daniel Fernandez-Guzman, Medalit Luna-Vilchez, Alvaro Taype-Rondan

    Our objective was to evaluate the frequency and characteristics of acute respiratory infections (ARI) with confirmed viral etiology in children treated at a Peruvian referral hospital before and during the COVID-19 pandemic between 2019 and 2022. We conducted a descriptive study based on the detection records of adenovirus, influenza A and B (IA and IB), parainfluenza 1-3 (PIV), metapneumovirus (hMPV), and respiratory syncytial virus (RSV). Of 1740 episodes (1220 patients), 14.4% tested positive: 196 (78.0%) RSV, 23 (9.2%) IA, 14 (5.6%) PIV-3, and 13 (5.2%) hMPV. In children under five years of age, RSV predominated, while in children over five years of age, it was IA. The frequency of ARI was lower with increasing age, during the pandemic (2020- 2021), and the spring and summer seasons. The higher frequency of respiratory viruses in 2022 highlights the need to maintain and strengthen surveillance and preparedness against these outbreaks.

  • Perceived Clinical Teaching Performance and Associated Factors Among Medical Students at a Peruvian University: a Cross-Sectional Study

    by Cristhian Rojas-Miliano, Jhojan Vargas-Armas, Jhonatan R. Mejia, María Custodio

    Objective To assess the characteristics and factors associated with the perception of clinical teaching performance among medical students at a Peruvian university. Methods We conducted a cross-sectional study in 2023 among medical students from the Universidad Nacional del Centro del Perú who had completed clinical rotations. A structured questionnaire was administered, comprising five sections: sociodemographic data; the “Motivated Strategies for Learning Questionnaire” (MSLQ) to assess intrinsic motivation; the “Depression Anxiety Stress Scale-21” (DASS-21) to measure stress, anxiety, and depression symptoms; clinical rotation characteristics; and a clinical teaching performance scale. Multiple linear regression was used to identify associated factors, adjusting for variables with p < 0.2 in bivariate analyses and additional confounders supported by existing literature. Results We analyzed 104 student responses covering 218 clinical rotations. Out of 54.8% were male, with a median age of 23 years (interquartile range [IQR]: 22–25). At least one inappropriate teaching behavior was reported in 11.9% of the clinical rotations, including disinterest (6%), verbal mistreatment (3.2%), unfair evaluation (2.8%), or sexual harassment/humor (1.4%). The median clinical teaching performance score was 124 (IQR: 112–142; range: 31–155). Significant associated factors included clinical rotations at public social security hospitals (β = -8.53; P = 0.006), perception of inappropriate teaching behaviors (β = -19.22; P = 0.001), and intrinsic motivation (β = 0.66; P = 0.027). Conclusions Overall, the perception of clinical teaching performance was positive, and it was significantly associated with the clinical rotation setting, perceived inappropriate teaching behaviors, and intrinsic motivation.

  • Open Access

    Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures: a modeling study

    by Ariel Bardach, Andrea Alcaraz, Jhonatan R. Mejia, Natalia Espinola, Elena Lazo, Federico Cairoli, Alfredo Palacios, Lucas Perelli, Federico Augustovski, Cesar Loza-Munarriz, et al.

    Objectives. To estimate the economic burden and disease burden associated with tobacco use in Peru and the projected effect of strengthening specific tobacco control measures. Materials and methods. We used a Markov microsimulation model to assess smoking-attributable mortality, disease events, economic costs, and projected benefits over ten years, considering the implementation of measures such as plain packaging, full enforcement of smoke-free laws, a complete ban on tobacco advertising, promotion, and sponsorship, and increased cigarette taxes. Results. Each year in Peru, approximately 22,350 deaths and 126,000 disease events are attributable to tobacco use, accounting for 19% of all deaths from heart disease, 18% of deaths from stroke, and 515,768 years of life lost. In addition, approximately 1.28% of gross domestic product is lost annually due to smoking. Over ten years, the implementation of plain packaging could prevent 6,218 deaths, 31,700 events, and save 576 million USD. Full compliance with smoke-free places would prevent 4,982 deaths, 25,400 events, and save 461 million USD. Banning advertising, promotion, and sponsorship could prevent 8,767 deaths, 44,700 events, and save 812 million USD. Increasing cigarette prices by 50% could prevent 20,400 deaths, 658,400 healthy life years lost, and an economic benefit of more than 3.3 billion USD. Conclusions. The economic and disease burden of tobacco use in Peru is significant. Greater efforts to control tobacco would significantly reduce this burden.


  • Diagnostic utility of artificial intelligence software through non-mydriatic digital retinography in the screening of diabetic retinopathy: an overview of reviews

    by Agustín Ciapponi, Jamile Ballivian, Carolina Gentile, Jhonatan R. Mejia, Jessica Ruiz-Baena, Ariel Bardach

    Objective To evaluate the capability of artificial intelligence (AI) in screening for diabetic retinopathy (DR) utilizing digital retinography captured by non-mydriatic (NM) ≥45° cameras, focusing on diagnosis accuracy, effectiveness, and clinical safety. Methods We performed an overview of systematic reviews (SRs) up to May 2023 in Medline, Embase, CINAHL, and Web of Science. We used AMSTAR-2 tool to assess the reliability of each SR. We reported meta-analysis estimates or ranges of diagnostic performance figures. Results Out of 1336 records, ten SRs were selected, most deemed low or critically low quality. Eight primary studies were included in at least five of the ten SRs and 125 in less than five SRs. No SR reported efficacy, effectiveness, or safety outcomes. The sensitivity and specificity for referable DR were 68–100% and 20–100%, respectively, with an AUROC range of 88 to 99%. For detecting DR at any stage, sensitivity was 79–100%, and specificity was 50–100%, with an AUROC range of 93 to 98%. Conclusions AI demonstrates strong diagnostic potential for DR screening using NM cameras, with adequate sensitivity but variable specificity. While AI is increasingly integrated into routine practice, this overview highlights significant heterogeneity in AI models and the cameras used. Additionally, our study enlightens the low quality of existing systematic reviews and the significant challenge of integrating the rapidly growing volume of emerging evidence in this field. Policymakers should carefully evaluate AI tools in specific contexts, and future research must generate updated high-quality evidence to optimize their application and improve patient outcomes.


  • Open Access

    Uso de medicamentos en pacientes pediátricos con COVID-19 hospitalizados en un hospital de referencia de Lima, Perú

    by Medalit Luna-Vilchez, Jhonatan R. Mejia, Zhamanda N. Ortiz-Benique, Mitsi Santiago-Abal, Alvaro Taype-Rondan

    This study aimed to describe the use of medication in pediatric patients with COVID-19 hospitalized at the National Children’s Health Institute - San Borja (INSN-SB) in Lima, Peru, between March 2020 and March 2022. Therefore, we conducted a descriptive, observational study to evaluate the use of six medications: corticosteroids, ceftriaxone, azithromycin, immunoglobulin, hydroxychloroquine, and ivermectin. We compared the results among subpopulations defined according to the COVID-19 pandemic waves. We included 421 pediatric patients. Corticosteroids were prescribed to 40.4%, ceftriaxone to 35.6%, azithromycin to 12.1%, immunoglobulin to 3.6%, hydroxychloroquine to 2.4%, and ivermectin to 0.5% of the patients. The use of ceftriaxone and azithromycin was less frequent during the third wave. Hydroxychloroquine was used almost exclusively during the first wave. Only patients with pediatric multisystem inflammatory syndrome used immunoglobulin. Overall, the prescription of the evaluated medications decreased during the third wave.


  • Open Access

    Determinants of adolescent pregnancy in indigenous communities from the Peruvian central jungle: a case–control study

    by Jhonatan R. Mejia, Ángel J. Quincho-Estares, Asstrid J. Flores-Rondon, Giancarlo Reyes-Beltran, Irene L. Arias-Sulca, Estephanie Palomino-Hilario, Jessica E. Barrientos-Cochachi, Carlos J. Toro-Huamanchumo

    Background: Adolescent pregnancy carries a high risk of severe health issues for both the mother and the newborn. Worldwide, 21 million adolescents give birth every year, with high percentages in Latin America. Most of the risk factors are met in indigenous communities, which is an underrepresented and poorly studied population. We aimed to assess the determinants of adolescent pregnancy in indigenous communities from the Peruvian central jungle. Methods: Through a case–control study, female adolescents aged 13 to 19 years old from seven indigenous communities of the Peruvian central jungle were interviewed. Adolescents with (cases) and with no (controls) pregnancy history, such as current pregnancy, children and abortion, fulfilled our eligible criteria. Our instrument explored: sociodemographic, adolescent and family characteristics, as well as perceptions of adolescent pregnancy. We performed a penalized maximum likelihood logistic regression analysis to obtain Odds Ratios (OR) and their 95% confidence intervals (95% CI). Results: We enrolled 34 cases and 107 controls. Overall, 53.9% were 15 to 19 years old. We found a significant association of being 15–19 years old (OR = 6.88, 95% CI 2.38–19.86, p < 0.0001) and an elementary school level of instruction (OR = 5.59, 95% CI 1.95–16.06, p = 0.001) with the risk of adolescent pregnancy. A marginal statistical significance between having five to six siblings and adolescent pregnancy was also reported (OR = 2.70, 95% CI 0.85–8.61, p = 0.094). Furthermore, adolescents with sexual and reproductive health communication with parents had a lower risk of adolescent pregnancy (OR = 0.17, 95% CI 0.06–0.47, p = 0.001). Conclusion: Our results suggest that public health and educational efforts should be age-specific focused within indigenous communities of the Peruvian central jungle, encouraging parents to talk about sexual and reproductive health topics with adolescents.


  • Open Access

    Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies

    by R. M. Carrillo‐Larco, D. J. Aparcana‐Granda, J. R. Mejia, N. C. Barengo, A. Bernabe‐Ortiz

    Aim: To summarize the evidence on diabetes risk scores for Latin American populations.Methods: A systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus, MEDLINE, Embase and Global Health) were searched. type 2 diabetes mellitus was defined using at least one blood biomarker and the reports needed to include information on the development and/or validation of a multivariable regression model. Risk of bias was assessed using the PROBAST guidelines.Results: Of the 1500 reports identified, 11 were studied in detail and five were included in the qualitative analysis. Two reports were from Mexico, two from Peru and one from Brazil. The number of diabetes cases varied from 48 to 207 in the derivations models, and between 29 and 582 in the validation models. The most common predictors were age, waist circumference and family history of diabetes, and only one study used oral glucose tolerance test as the outcome. The discrimination performance across studies was ~ 70% (range: 66–72%) as per the area under the receiving‐operator curve, the highest metric was always the negative predictive value. Sensitivity was always higher than specificity.Conclusion: There is no evidence to support the use of one risk score throughout Latin America. The development, validation and implementation of risk scores should be a research and public health priority in Latin America to improve type 2 diabetes mellitus screening and prevention.


  • Open Access

    Infecciones oportunistas post inicio de tratamiento antirretroviral en pacientes con VIH/SIDA en un hospital público de Perú

    by Raúl Héctor Montalvo, Jhonatan R Mejía, Percy Ramírez, Eder Rojas, Henry Serpa, Víctor Tiza

    Introducción: El Tratamiento antirretroviral (TAR) suprime la replicación viral del VIH aun así ocurre las infecciones oportunistas (IOs) post inicio del TAR. Objetivo: Identificar y comparar las infecciones oportunistas (IOs) en pacientes con infección por VIH/SIDA que inician TAR en un hospital público de Perú. Materiales y métodos: Se realizó un estudio observacional de cohorte prospectivo de 8 años de seguimiento a los pacientes con infección por VIH/SIDA que iniciaron TAR. Resultados: De 427 pacientes estudiados, 111 (26%) presentaron por lo menos una infección oportunista. Los pacientes que presentaron IOs tuvieron una media de CD4: 107,5 células /ml, mientras que este conteo fue más alto en los pacientes sin coinfección (p<0,01), la carga viral no está relacionada con la presencia de IOs (p = 0,48). Las infecciones más frecuentes fueron: tuberculosis (43,2%), diarrea crónica (29,7%), candidiasis (10,8%), toxoplasmosis, citomegalovirus (4,5%) y Pneumocistosis (3,6%). Conclusiones: A pesar de los avances en el manejo de la infección por VIH/SIDA, las IOs continúan siendo la principal causa de hospitalización y la tuberculosis es el factor más importante asociado a mortalidad.

  • Open Access

    Mortalidad en pacientes con infección por VIH/SIDA en tratamiento antiretroviral en Huancayo, Perú 2008-2015

    by Raúl Montalvo, Jhonatan Mejía, Percy Ramírez, Eder Rojas, Henry Serpa, Mercedes Gomez, Frank Quispe

    Objetivo: Evaluar la mortalidad en pacientes con infección por VIH/SIDA que reciben tratamiento antirretroviral (TAR) en un hospital público de Perú. Materiales y métodos: Se realizó un estudio observacional de cohorte retrospectivo de los pacientes con diagnóstico de infección por VIH/SIDA que recibieron tratamiento antirretroviral. Resultados: De 428 pacientes estudiados, la media de edad fue 37 años y la media del recuento de CD4 al inicio del TAR en el grupo de fallecidos fue 87,2 cels/uL frente a 153,2 cels/uL en el grupo de vivos, fallecieron 66 pacientes (15,4%) después de iniciar TAR. La mayoría (48,5%) de estos pacientes tenían recuento de CD4 menor de 200 cel/uL, 59,1% desarrollaron infección oportunista y 16,7% cambiaron de esquema antirretroviral en algún momento del TAR. La mortalidad durante los primeros 3 meses de TAR fue 32,6%; el análisis con múltiples variables se encontró asociación con tener CD4 mayor de 100 cel/mL (HR:0,57; IC95%: 0,29-1,11), la presencia de infección oportunista (HR: 1,1; IC95% 1,06-1,16) y tener una alta carga viral (HR 1,17; IC95%:1,07-1,48). La probabilidad de sobrevida de los pacientes con CD4 menor de 100 cel/mL a los 8 años en TAR es 68%. Conclusiones: El mayor número de muertes de los pacientes con infección por VIH/SIDA ocurre durante los tres primeros meses de TAR y está asociado a un diagnóstico tardío (alta carga viral, bajo CD4 y presencia de enfermedades oportunistas). Sugerimos la implementación de terapia supervisada durante los primeros meses de TAR en pacientes con CD4 menor de 100 cel/mL, para identificar en forma temprana las infecciones oportunistas.